ArticleBreast cancer research and treatment2020

Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study).

Santiago González-Santiago et al.PubMed ↗Publisher ↗

No numbers read from the abstract.